NL-OMON50903已完成不适用
A Randomized, Double-blind, Placebo-controlled study to investigate the efficacy of oleuropein on skeletal muscle energy metabolism and fatigue in humans - Oleuropein and muscle energy metabolism
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •2. 50 to 70 years old
- •3. BMI 18.5-29.9 kg/m2
- •4. Healthy
- •5. Having given informed consent
排除标准
- •1. Allergy/intolerance to the study product
- •2. >5% body mass change in the previous 3 months
- •3. HbA1c * 6.5%
- •4. Blood pressure: systolic/diastolic >140/ and >90 mmHg (when both conditions
- •5. Participating in a structured (progressive) exercise program
- •6. Smoking
- •7. Diagnosed acute or chronic medical conditions that, could impact study
- •8. Diagnosed musculoskeletal disorders
- •9. Chronic use of gastric acid suppressing medication
- •10. Unauthorized concomitant medications such as calcium antagonists (e.g.
- •valproate), oral corticosteroids, anything that will prevent subjects from
- •safely completing the study according to the investigator or medications /
- •drugs known interfering with the expected mechanism of action of IP or to
- •affect the outcome parameters
- •11. Alcohol (intake higher than 3 servings per day. One serving is 0.4 dl of
- •alcohol, 1 dl of wine, or 3 dl of beer) or drug abuse
- •12. Overly imbalanced or restrictive diet (e.g. hyperproteic, vegan, ketogenic,
- •13. Subjects not willing and/or not able to comply with scheduled visits and
- •the requirements of the study protocol
- •14. Any implants that would be a contra-indication for performing an MRI scan.
- •15. Participation in another study at the same time
- •16. Blood donnation in the previous 2 months
- •17. Non-Dutch speaking
研究者
相似试验
进行中（未招募）
1 期
This is a study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects with Moderately to Severely Active Crohn's Disease (CD)Subjects with moderately to severely active Crohn's diseaseMedDRA version: 20.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2021-002869-18-BEAbbVie Deutschland GmbH & Co. KG265
进行中（未招募）
1 期
Clinical Trial to compare if seriously-ill adults with constipation due to narcotics have bowel movements sooner after injection with Methylnatrexone or placeboEUCTR2007-000854-30-BESalix Pharmaceuticals Inc254
进行中（未招募）
不适用
A study to evaluate the effect and safety of a 4 week treatment plan of Alirocumab in patients with high cholesterolPrimary HypercholesterolemiaMedDRA version: 17.0Level: LLTClassification code 10020604Term: HypercholesterolemiaSystem Organ Class: 100000004861EUCTR2013-002343-29-GBRegeneron Pharmaceuticals, Inc.803
进行中（未招募）
不适用
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of E5555, and its Effects on Markers of Intravascular Inflammation in Subjects with Coronary Artery Disease - E5555-G000-201Coronary Artery DiseaseMedDRA version: 8.1Level: PTClassification code 10011078EUCTR2005-006029-94-BEEisai Limited720
已完成
不适用
A Randomized, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of JNJ-26070109abdominal pain and heartburn10017943NL-OMON30044Janssen-Cilag82